Development of enzyme-linked immunosorbent assay for acidic fibroblast growth factor and its clinical application

Clinica Chimica Acta

Volumn 283, Issue 1-2, 1999, Pages 171-182

  Ikemoto, Masaki ^a   Hasegawa, Koji ^b   Kihara, Yasuki ^b   Iwakura, Atsushi ^b   Komeda, Masashi ^b   Yamazato, Ario ^c   Fujita, Masatoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Center for Cerebrovascular Disease   (Japan)

Author keywords

aFGF; Coronary artery disease; ELISA; Growth factor; Pericardial fluid

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANIMALS; CALIBRATION; CORONARY DISEASE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERICARDIAL EFFUSION; RABBITS; REFERENCE VALUES;

ANGINA; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 0032782408     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00045-5     Document Type: Article

References (14)

1. Baird A., Esch F., Mordede P., et al. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res. 42:1986;143-205.
2. Gospodarowicz D. Isolation and characterization of acidic and basic fibroblast growth factor. Methods Enzymol. 147:1987;106-119.
3. Burgess W.H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem. 58:1989;575-606.
4. Gospodarowicz D., Moran J. Effect of a fibroblast growth factor, insulin, dexamethasone, and serum on the morphology of BALB/c 3T3 cells. Proc Natl Acad Sci USA. 71:1974;4648-4652.
5. Gospodarowicz D., Ferrara N., Schweigerer L., Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 8:1987;95-114.
6. Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 128:1986;475-484.
7. Neufeld G., Gospodarowicz D. Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J Biol Chem. 261:1986;5631-5637.
8. Lobb R.R., Harper J.W., Fett J.W. Purification of heparin-binding growth factors. Anal Biochem. 154:1986;1-14.
9. Fujita M., Ikemoto M., Kishishita M., et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 94:1996;610-613.
10. Fujita M., Ikemoto M., Tanaka T., et al. Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris. Angiogenesis. 2:1998;105-108.
11. Braunwald E. Unstable angina: a classification. Circulation. 80:1989;410-414.
12. Rentrop K.P., Cohen M., Blanke H., et al. Changes in collateral filling immediately following controlled coronary artery occlusion by an angioplasty balloon in man. J Am Coll Cardiol. 5:1985;587-592.
13. Thomas K.A. Biochemistry and molecular biology of fibroblast growth factors. Fallon J.H., Loughlin S.E. Neurotropic factors. 1992;285-312 Academic Press, Orlando, FL.
14. Bjornsson T.D., Dryjski M., Tluczek J., et al. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA. 88:1991;8651-8655.